Literature DB >> 21368030

RTP801/REDD1 regulates the timing of cortical neurogenesis and neuron migration.

Cristina Malagelada1, Miguel Angel López-Toledano, Ryan T Willett, Zong Hao Jin, Michael L Shelanski, Lloyd A Greene.   

Abstract

The generation, differentiation, and migration of newborn neurons are critical features of normal brain development that are subject to both extracellular and intracellular regulation. However, the means of such control are only partially understood. Here, we show that expression of RTP801/REDD1, an inhibitor of mTOR (mammalian target of rapamycin) activation, is regulated during neuronal differentiation and that RTP801 functions to influence the timing of both neurogenesis and neuron migration. RTP801 levels are high in embryonic cortical neuroprogenitors, diminished in newborn neurons, and low in mature neurons. Knockdown of RTP801 in vitro and in vivo accelerates cell cycle exit by neuroprogenitors and their differentiation into neurons. It also disrupts migration of rat newborn neurons to the cortical plate and results in the ectopic localization of mature neurons. On the other hand, RTP801 overexpression delays neuronal differentiation. These findings suggest that endogenous RTP801 plays an essential role in temporal control of cortical development and in cortical patterning.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21368030      PMCID: PMC3089438          DOI: 10.1523/JNEUROSCI.4011-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase.

Authors:  Rolf Schwarzer; Daniel Tondera; Wolfgang Arnold; Klaus Giese; Anke Klippel; Jörg Kaufmann
Journal:  Oncogene       Date:  2005-02-10       Impact factor: 9.867

2.  Downregulation of activating transcription factor 5 is required for differentiation of neural progenitor cells into astrocytes.

Authors:  James M Angelastro; Jeffrey L Mason; Tatyana N Ignatova; Valery G Kukekov; George B Stengren; James E Goldman; Lloyd A Greene
Journal:  J Neurosci       Date:  2005-04-13       Impact factor: 6.167

3.  The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway.

Authors:  Michael N Corradetti; Ken Inoki; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 4.  Dysregulation of the TSC-mTOR pathway in human disease.

Authors:  Ken Inoki; Michael N Corradetti; Kun-Liang Guan
Journal:  Nat Genet       Date:  2005-01       Impact factor: 38.330

5.  Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS.

Authors:  L Feng; M E Hatten; N Heintz
Journal:  Neuron       Date:  1994-04       Impact factor: 17.173

6.  Neurogenic effect of beta-amyloid peptide in the development of neural stem cells.

Authors:  Miguel A López-Toledano; Michael L Shelanski
Journal:  J Neurosci       Date:  2004-06-09       Impact factor: 6.167

7.  Temporal control of differentiation by the insulin receptor/tor pathway in Drosophila.

Authors:  Joseph M Bateman; Helen McNeill
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

Review 8.  Tuberous sclerosis-related gene expression in normal and dysplastic brain.

Authors:  H V Vinters; C Kerfoot; M Catania; J K Emelin; S N Roper; J E DeClue
Journal:  Epilepsy Res       Date:  1998-09       Impact factor: 3.045

9.  The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila.

Authors:  Jan H Reiling; Ernst Hafen
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

10.  Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

Authors:  James Brugarolas; Kui Lei; Rebecca L Hurley; Brendan D Manning; Jan H Reiling; Ernst Hafen; Lee A Witters; Leif W Ellisen; William G Kaelin
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

View more
  26 in total

1.  CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.

Authors:  Javier Palazuelos; Zaira Ortega; Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

2.  Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.

Authors:  Vinit V Patil; Miguel Guzman; Angela N Carter; Geetanjali Rathore; Daniel Yoshor; Daniel Curry; Angus Wilfong; Satish Agadi; John W Swann; Adekunle M Adesina; Meenakshi B Bhattacharjee; Anne E Anderson
Journal:  Neuropathology       Date:  2015-09-18       Impact factor: 1.906

Review 3.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

4.  RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.

Authors:  Núria Martín-Flores; Joan Romaní-Aumedes; Laura Rué; Mercè Canal; Phil Sanders; Marco Straccia; Nicholas D Allen; Jordi Alberch; Josep M Canals; Esther Pérez-Navarro; Cristina Malagelada
Journal:  Mol Neurobiol       Date:  2015-04-16       Impact factor: 5.590

5.  Distinct germline progenitor subsets defined through Tsc2-mTORC1 signaling.

Authors:  Robin M Hobbs; Hue M La; Juho-Antti Mäkelä; Toshiyuki Kobayashi; Tetsuo Noda; Pier Paolo Pandolfi
Journal:  EMBO Rep       Date:  2015-02-19       Impact factor: 8.807

Review 6.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

7.  Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms.

Authors:  Yan Yan; Xiaofeng Zhou; Zui Pan; Jianjie Ma; James A Waschek; Emanuel DiCicco-Bloom
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

8.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

Review 9.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

Review 10.  mTOR: on target for novel therapeutic strategies in the nervous system.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang
Journal:  Trends Mol Med       Date:  2012-12-19       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.